Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 9128 | 1118 | 37.6 | 77% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | JENS | Address | 17 | 79% | 1% | 11 |
| 2 | BEHAV HLTH CLIN NEUROSCI | Address | 10 | 40% | 2% | 19 |
| 3 | NW HEPATITIS OURCE C | Address | 7 | 67% | 1% | 6 |
| 4 | NW HEPATITIS C OURCE | Address | 6 | 41% | 1% | 12 |
| 5 | CLDQ | Author keyword | 4 | 75% | 0% | 3 |
| 6 | CHRONIC LIVER DISEASE QUESTIONNAIRE | Author keyword | 3 | 57% | 0% | 4 |
| 7 | LIVER SPECIFIC QUALITY OF LIFE | Author keyword | 3 | 100% | 0% | 3 |
| 8 | PSYCHIAT PSYCHOTHER Y ADDICT MED | Address | 3 | 31% | 1% | 8 |
| 9 | YULIUS | Address | 3 | 50% | 0% | 4 |
| 10 | CLDQ HCV | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ALPHA INDUCED DEPRESSION | 35 | 67% | 3% | 32 |
| 2 | INTERFERON INDUCED DEPRESSION | 19 | 61% | 2% | 20 |
| 3 | INDUCED DEPRESSION | 11 | 30% | 3% | 31 |
| 4 | BIOPSYCHOSOCIAL PREDICTORS | 11 | 100% | 1% | 6 |
| 5 | CLDQ | 11 | 100% | 1% | 6 |
| 6 | INDUCED DEPRESSIVE SYMPTOMS | 11 | 100% | 1% | 6 |
| 7 | ALFA INTERFERON | 10 | 45% | 2% | 17 |
| 8 | RECOMBINANT HUMAN INTERFERON | 10 | 48% | 1% | 15 |
| 9 | RECEIVING INTERFERON ALPHA 2B | 5 | 63% | 0% | 5 |
| 10 | INDUCED MOOD DISORDER | 4 | 67% | 0% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens | 2015 | 5 | 98 | 44% |
| Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis | 2012 | 51 | 60 | 53% |
| Neuropsychiatric adverse effects of interferon-alpha - Recognition and management | 2005 | 206 | 84 | 57% |
| The effects of HCV infection and management on health-related quality of life | 2007 | 86 | 70 | 64% |
| Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update | 2011 | 25 | 53 | 64% |
| Cognitive dysfunction in chronic hepatitis C: A review | 2008 | 50 | 100 | 56% |
| Insights from interferon-alpha-related depression for the pathogenesis of depression associated with inflammation | 2014 | 7 | 135 | 36% |
| Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review | 2000 | 272 | 81 | 48% |
| Hepatitis C and Work Impairment A Review of Current Literature | 2014 | 5 | 26 | 46% |
| Interferon-induced depression in chronic hepatitis C: A review of its prevalence, risk factors, biology, and treatment approaches | 2006 | 84 | 115 | 42% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | JENS | 17 | 79% | 1.0% | 11 |
| 2 | BEHAV HLTH CLIN NEUROSCI | 10 | 40% | 1.7% | 19 |
| 3 | NW HEPATITIS OURCE C | 7 | 67% | 0.5% | 6 |
| 4 | NW HEPATITIS C OURCE | 6 | 41% | 1.1% | 12 |
| 5 | PSYCHIAT PSYCHOTHER Y ADDICT MED | 3 | 31% | 0.7% | 8 |
| 6 | YULIUS | 3 | 50% | 0.4% | 4 |
| 7 | DIP O TES DINIZ | 2 | 67% | 0.2% | 2 |
| 8 | HEPATOL NEUROBEHAV PROGRAM | 2 | 67% | 0.2% | 2 |
| 9 | PORTLAND GASTROENTEROL | 2 | 67% | 0.2% | 2 |
| 10 | BETTY GUY BEATTY INTEGRATED | 2 | 15% | 1.1% | 12 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000189027 | INJECTING DRUG USE//HEPATITIS C TREATMENT//VIRAL HEPATITIS CLIN PROGRAM |
| 2 | 0.0000139883 | INHIBITORY MODULATION//TAC ANTIGEN//PROGRAMA NEUROIMUNOL NEUROBIOL |
| 3 | 0.0000139843 | MAES CLIN TRIA//IMUNOL ENVELHECIMENTO//NEUROL FONCTIONNELLE EPILEPTOL |
| 4 | 0.0000102235 | TELAPREVIR//RIBAVIRIN//BOCEPREVIR |
| 5 | 0.0000101884 | INTERFERON ASSOCIATED RETINOPATHY//HUNTER MAIL REG//CHRONIC ACTIVE HEPATITIS C |
| 6 | 0.0000086330 | OCCULT HCV//OCCULT HEPATITIS C//OCCULT HCV INFECTION |
| 7 | 0.0000066002 | BEHAV HLTH JUSTICE PUBL POLICY//CHRONICALLY AND VARIABLY IMPAIRED AUTONOMY//PENN AIDS |
| 8 | 0.0000058022 | HEPAT BILIARY PANCREAT SURG LIVER TRANSPLANT UN//ALCOHOL RECIDIVISM//COORDINAC SECTORIAL TRASPLANTES |
| 9 | 0.0000052510 | CHRONIC HEPATITIS C//INTERFERON THERAPY//HCV RNA |
| 10 | 0.0000048742 | MOS HIV//WHOQOL HIV BREF//WHOQOL HIV |